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Abstract
Background: Standard test data are still preferred and recommended for regulatory environmental risk
assessments of pharmaceuticals even though data generated by non-standard tests could improve the scientific
basis of risk assessments by providing relevant and more sensitive endpoints.
The aim of this study was to investigate if non-standard ecotoxicity data can be evaluated systematically in risk
assessments of pharmaceuticals. This has been done by evaluating the usefulness of four reliability evaluation
methods, and by investigating whether recently published non-standard ecotoxicity studies from the open
scientific literature fulfill the criteria that these methods propose.
Results: The same test data were evaluated differently by the four methods in seven out of nine cases. The
selected non-standard test data were considered reliable/acceptable in only 14 out of 36 cases.
Conclusions: The four evaluation methods differ in scope, user friendliness, and how criteria are weighted and
summarized. This affected the outcome of the data evaluation.
The results suggest that there is room for improvements in how data are reported in the open scientific literature.
Reliability evaluation criteria could be used as a checklist to ensure that all important aspects are reported and
thereby increasing the possibility that the data could be used for regulatory risk assessment.
Background
Environmental risk assessment of pharmaceuticals
In 2006, the European Medicines Agency (EMA)
decided that all new marketing authorisation applica-
tions for human pharmaceuticals should be accompa-
nied by an environmental risk assessment [1]. The EMA
risk assessment has a PEC/PNEC (predicted environ-
mental concentration/predicted no effect concentration)
approach and is divided into two phases. In phase II,
data on the substance’s physicochemical properties, per-
sistence and bioaccumulation, and ecotoxicity are
reviewed and the PNEC is estimated. All relevant data
should be taken into account. Experimental studies
should preferably follow standard test protocols but it is
recognized that there are other acceptable methods.
However, their use should be justified and studies
should be conducted in compliance with good labora-
tory practices (GLP) [1].
Standard and non-standard ecotoxicity tests
Ecotoxicological testing can be done using a variety of
methods and models. There are two general approaches:
using standard or non-standard testing methodologies.
Standard tests refer to tests performed and reported
according to a method described and provided by an offi-
cial international or national harmonization or standardi-
zation organization, such as the OECD (Organisation for
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Economic Cooperation and Development), US EPA (Uni-
ted States Environmental Protection Agency), ASTM
(American Society for Testing and Materials), AFNOR
(Association Française de Normalisation), and ISO
(International Organization for Standardization). The test
standard establishes a uniform specification of the experi-
mental setup and execution, methods for data analyses,
and the reporting format for the test data. Non-standard
tests, on the other hand, are tests performed according to
any other test method.
Regardless of whether a test is performed according to
a standard or not, they should meet some general scien-
tific quality criteria to demonstrate the reliability and
reproducibility of the test results. Examples of such gen-
eral scientific quality criteria are a clear description of
the endpoints, inclusion of appropriate controls, appro-
priate identification of test substance and test organism,
stated exposure duration time and administration route,
and transparent reporting of effect concentrations.
The major advantages of using standard tests are that
the results are directly comparable across substances and
that the data they generate will be readily accepted across
jurisdictions. Test guidelines also contributes to promote
the reliability of the data by making it easier to repeat the
experiment if needed because of the detailed standard test
procedures and extensive reporting of data that is
required. The major disadvantage of standard test meth-
ods is that it does not always represent the most biologi-
cally relevant testing approach depending on the type of
endpoint under investigation. Therefore, results from non-
standardized tests may in some cases be more sensitive
and thereby contribute additional and significant informa-
tion to a risk assessment. Other disadvantages of standard
tests are that they are inflexible and therefore there is no
room for case-by-case adjustments and that it may take up
to 10-15 years to develop a new standard test.
Given the characteristics and purposes of standard tests,
it is not surprising that they are mostly performed by com-
mercial laboratories while non-standardized methods are
typically performed by research scientists and published in
scientific journals. Standard tests are often performed
according to GLP, whereas non-standard tests are seldom
performed according to GLP. The primary objective of the
OECD Principles of Good Laboratory Practice is to ensure
the generation of high-quality and reliable test data related
to the safety of chemical substances and preparations [2].
But concerns have also been raised regarding whether
GLP is synonymous with good scientific practices, accu-
rate reporting and valid data [3,4].
Testing for environmental effects caused by
pharmaceutical substances
Pharmaceutical substances have a number of inherent
properties that make them interesting from a regulatory
perspective. First, pharmaceuticals are carefully designed
to interact with biological processes. Second, this inter-
action should be as specific as possible, ideally influen-
cing only one well-defined target molecule or cellular
process, and have as few other side effects as possible.
Third, this interaction should be achieved at low con-
centrations, meaning that the substance has to be rela-
tively potent. Fourth, to achieve this, it is necessary that
the active pharmaceutical ingredient is sufficiently per-
sistent to remain un-metabolized long enough to reach
the target organ in the human body.
It is fundamental for risk identification, and thus a
crucial part of the risk assessment process, to have toxi-
city test methods that are adapted to their purpose. Cur-
rently available standard test methods for deriving
regulatory toxicity data for the aquatic environment are
in many cases not sufficiently sensitive to the types of
very specific effects that can be expected from pharma-
ceutical substances [see e.g., [5]]. The EMA guideline [1]
recommends that standard tests measuring growth inhi-
bition and reproduction failure are used in environmen-
tal risk assessment of pharmaceutical substances (OECD
test number 201, 210 and 211). However, test data are
for many pharmaceuticals still limited or not publically
available. The sex hormone ethinylestradiol is one of
few substances where a significant amount of both stan-
dard and non-standard test data is available. Table 1
presents the lowest reported standard and non-standard
effect values (according to the Wikipharma database [6]
and the environmental classification system at fass.se
[7]), both no-observed effect concentration (NOEC) and
EC50 values (lowest identified effect concentration where
50% of the tested population have been found to be
affected), for ethinylestradiol.
When comparing toxicity values, the non-standard
NOEC value is 32 times lower than the standard test
NOEC value, and the non-standard EC50 value is over
95,000 times lower than the standard EC50 value. Ethi-
nylestradiol can therefore be seen as an example where
non-standard tests with more substance-specific end-
points are more sensitive compared to the standard
tests.
There is a need to carefully evaluate the regulatory
process of identifying pharmaceuticals that might pose a
risk to non-target species in the aquatic environment,
and make sure that relevant and sufficiently sensitive
tests are used in the regulatory environmental risk
assessment of pharmaceuticals. As we see it, there are at
least three ways forward: (1) to develop new standard
ecotoxicity tests better suited for pharmaceuticals, or (2)
to adjust existing standard tests by supplementing them
with additional endpoints relevant for different pharma-
cological modes-of-action, or (3) to increase the use of
non-standard tests for risk assessment purposes.
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The development of new test standards is costly and
may take up to 10 to 15 years [8] and since pharmaceu-
ticals are a diverse group of substances when it comes
to how they affect biological processes it is unlikely that
new standards that would cover all relevant endpoints,
could be developed in the near future.
Adjustments of current standard tests could increase
the biological relevance for testing pharmaceutical sub-
stances. Therefore, a potential way forward could be
that the standardization organizations initiate additional
validation and expert commenting rounds, to standar-
dize such adjustments. Still, such minor additions of
existing standards would likely not be sufficient to
ensure that the specific biological effects of most phar-
maceuticals are covered by the tests.
Hence, in our view, an important and realistic way
forward is to make increased use of non-standard test
data to ensure a scientifically well-founded environmen-
tal risk assessment of pharmaceuticals. To enable the
use of non-standard tests in risk assessments, two things
are needed: that the legislation is designed so that non-
standard tests can be included in a systematic and pre-
dictable way, and that non-standard tests are reported
in a transparent and comprehensive way, much like
required when using the standard test methods.
Reliability and relevance evaluation of (eco-)toxicity data
According to the TGD [9], an evaluation of data reliabil-
ity should ensure “the inherent quality of a test relating
to test methodology and the way that the performance
and results of the test are described”. Basically, this eva-
luation should answer the question: has the experiment
generated and reported a true and correct result?
The assessment of the relevance of the data should
describe “the extent to which a test is appropriate for a
particular hazard or risk assessment” [9], e.g., answer
questions like: Is the measured endpoint a valid indica-
tor of environmental risk? Is the experimental model
sufficiently sensitive in relation to detecting the expected
effects? Has the experimental model a sufficient
statistical power? How representative is the experimental
model to the environment that is aimed to be protected?
Evaluation of data can be done within different frame-
works. It usually relies to a significant extent on case-by-
case assessments based on expert judgment. However,
there have also been attempts to make the evaluation
process more structured. Such an approach can include
checklists or even pre-defined evaluation criteria. A
major advantage of using a structured way of evaluating
data is increased transparency and predictability of the
risk assessment process. For instance, both a checklist
and pre-defined criteria will contribute to ensuring that
at least a minimum and similar set of aspects are consid-
ered in each evaluation. Pre-defined evaluation criteria
may also contribute to increased transparency of the eva-
luation process to the extent that these criteria are clearly
reported to the relevant parties. Disadvantages of using
pre-defined evaluation criteria or checklists are that they
are obviously less flexible and need to focus on the gen-
eral aspects of a study. In general, there is a need to strike
a balance between flexibility and predictability in the data
quality evaluation process; it will always include an ele-
ment of expert judgment, but it is also, in our view,
important to continuously seek to increase the predict-
ability and transparency of this process.
Aim
The overall aim of this study was to investigate if the
reliability of non-standard ecotoxicity data can be evalu-
ated systematically in environmental risk assessments of
pharmaceutical substances. Our hypothesis was that eva-
luation and reporting criteria can contribute to making
the evaluation more systematic, predictable, and trans-
parent, and facilitate the use of non-standard data for
risk assessment purposes.
Method
This study is divided into two parts: (1) an evaluation of
the usefulness of four methods for reliability evaluation
of test data that have been proposed in the scientific
Table 1 The lowest publically available standard and non-standard effect values for ethinylestradiola
Test standard Test species Endpoint Effect values Reference
OECD 201b Desmodesmus spp
(algae)





Danio rerio (fish) Condition factor (comprising effects on weight and
length)
NOEC 0.00001 mg/Lc [35]
OECD 211b Daphnia (crustacean) Reproduction EC50 0.105 mg/L [36]
Non-standard test Danio rerio (fish) Spawning, egg production, fertilization NOEC 0.00000031 mg/L [37]
Non-standard test Danio rerio (fish) Fertilization success EC50 0.0000011 mg/L [38]
aAccording to the Wikipharma database [3] and the environmental classification system at http://www.fass.se[ 4]. bRecommended for use in environmental risk
assessments of pharmaceuticals (EMA, 2006); cThe highest tested concentration.
OECD Organisation for Economic Cooperation and Development, NOEC no observed effect concentration. EC50 lowest identified effect concentration where 50%
of the tested population have been found to be affected.
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literature, and (2) an investigation of whether recently
published non-standard ecotoxicity studies from the
open scientific literature fulfill these reliability criteria.
Evaluation of existing reliability evaluation methods
The four evaluation methods used in this study are
described by Klimisch et al. [10], Durda and Preziosi
[11], Hobbs et al. [12], and Schneider et al. [13]. The
reporting requirements from the OECD guidelines 201,
210, and 211 were used as a reference in the evaluation
of the four methods. The reporting requirements were
merged and generalized into 37 criteria so that they
could be used on all types of endpoints and organisms.
Investigation whether published non-standard ecotoxicity
studies fulfill proposed reliability criteria
The non-standard test data evaluated in this study (pre-
sented in Table 2[14-22]) have been selected for the
current analyses since they were either (1) used in risk
assessments of active pharmaceutical ingredients within
the Swedish environmental classification and informa-
tion system for pharmaceuticals [[23]; available at http://
www.fass.se] or (2) used in a previous evaluation of this
classification system [24]. These selection criteria
resulted in a total of nine references that was then eval-
uated according to the four methods. Some references
contain several ecotoxicological studies but only the part
of the reference relevant for the chosen effect value was
considered in this evaluation. Some of the evaluated stu-
dies could have been conducted according to a standar-
dized method but since this is not reported in the
reference, the study is treated as a non-standard test.
Results
The results section is divided into the following sections:
hypothesis and endpoints (Table 3), protocol (Table 4),
test substance (Table 5), test environment (Table 6),
dosing system (Table 7), test species (Table 8), controls
(Table 9), statistical design (Table 10), and biological
effect (Table 11). Each section is reported and discussed
in two parts; (1) an evaluation of the usefulness of exist-
ing proposed criteria for reliability evaluation of test
data, and (2) an investigation of whether the evaluated
non-standard study fulfill the proposed reliability cri-
teria. The two parts are also summarized in the end
(Summary of the evaluation of existing reliability evalua-
tion methods and Summary of the reliability evaluation
of the non-standard test data sections).
Hypothesis and endpoint
Usefulness of proposed criteria
All four evaluation methods consider that study end-
points should be stated and described. Durda and Pre-
ziosi [11] also considers hypothesis important for
studies where NOEC or LOEC (lowest observed effect
concentration) values are identified, and involves a
Table 2 Overview of the non-standard effect data evaluated in this study
Reference Pharmaceutical
substance
Endpoint Test species and effect value
Andreozzi et al. [14] Amoxicillin Growth inhibition Synechococcus leopoliensis
NOEC (96 h) 0.78 μg/L
Ferrari et al. [15] Ofloxacin Growth inhibition Synechococcus leopolensis
EC50 (96 h) 16 μg/L
Ferrari et al. [15] Sulfamethoxazole Growth inhibition Synechococcus leopoliensis
EC50 (96 h) 26.8 μg/L
Ferrari et al. [15] Propranolol Growth inhibition Pseudokirchneriella subcapitata
NOEC (96 h) 5 mg/L Synechococcus leopolensis NOEC (96 h)
0.35 mg/L
Huggett et al. [16] Propranolol Number of eggs and percent hatch Oryzias latipes
LOEC (4 weeks) 0.5 μg/L
Robinson et al. [17] Levofloxacin Growth inhibition Pseudokirchneriella subcapitata
EC50 (72 h) 7.4 mg/L
Schmitt-Jansen et al.
[18]
Diclofenac Cell reproduction Scenedesmus vacuolatus
EC50 (24 h) 0.023 mg/L
Quinn et al. [19] Ibuprofen Morphology changes Hydra attenuata
EC50 (96 h) 1.65 mg/L
Metcalfe et al. [20] Estradiol Induced intersex (testis-ova) Oryzias latipes
NOEL (90 days) 0.0004 μg/L
Nentwig [21] Fluoxetine Reproduction inhibition Potamopyrgus antipodarum
NOEC (56 days) 0.47 μg/L
Halm et al. [22] Estradiol P450aromB mRNA expression in the
brain
Pinephales promelas
LOEC (4 days) 100 ng/L
NOEC/L no observed effect concentration/level, LOEC lowest observed effect concentration, EC50 lowest identified effect concentration where 50% of the tested
population have been found to be affected.
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relevance criterion by asking whether the chosen end-
point is appropriate for the hypothesis. No OECD
guideline criteria matched this category.
Result of the study evaluations
The nine selected studies report NOEC/LOEC values
and EC50 values, but none of the studies selected for
this evaluation clearly stated a hypothesis. Instead end-
points were described, in some cases very thoroughly
and in other cases hardly at all. Describing why a speci-
fic endpoint was used will help clarify the importance
of the conducted study. It should be noted that it has
been argued that hypotheses should be replaced by
dose-response analysis when deriving exotoxicological
benchmarks [25-28].
Protocol
Usefulness of proposed criteria
Both Klimisch et al. [10] and Durda and Preziosi [11]
have evaluation criteria that are wide and imprecise
which opens up for a variety of different interpretations
and opinions.
Schneider et al. [13] evaluation question is also wide
and concerns relevance, rather than reliability. In the
accompanying guidance material to the question, a
variety of aspects are included: the chosen test system
and its applicability domain, consideration of physio-
chemical properties and stability of test substance, num-
ber of replicates, number of concentration levels and
their range and spread, suitability of administration
method, inclusion of all relevant endpoints, and statisti-
cal evaluation. The method would benefit from separat-
ing these aspects into several questions.
Result of the study evaluations
For three of the selected studies, a clear description of
the test procedure was lacking, the majority of the stu-
dies would benefit from improving their reporting of the
study. The chosen study designs were in all cases rele-
vant for the data aimed at.
Test substance
Usefulness of proposed criteria
Identification of test compound, source, physicochemical
properties such as purity and stability, and other sub-
stances used are factors related to the “test compound”
that the four evaluation methods together consider
important, but none of the methods report all factors.
Purity is the only factor reported by all four methods.
Water solubility is not reported explicitly but can be
Table 3 Modified evaluation criteria/questions concerning endpoints and a summary of the evaluation results
Evaluation
method






Data on the measured parameters (including definitions). Recommended Data is presented but
endpoints are not clearly
defined in at least two studies.
Durda and
Preziosi True
Hypothesis clearly defined for studies where NOEC or LOEC values are identified. Recommended The hypothesis is not stated in
any of these studies.
Endpoints appropriate for hypothesis. Recommended Endpoints appropriate for
dose-response analyses.
Hobbs et al. Was the biological endpoint (e.g., immobilization or population growth) stated
and refined (10 marks)? Award 5 marks if the biological endpoint is only stated.




Are the study endpoint(s) and their method(s) of determination clearly described? Recommended,
0, or 1
Not clearly defined in at least
two studies.




Evaluation criteria/question Type of
criteria/mark
Summary of evaluation results
Klimisch
et al.
Clear description of the test procedure (complete documentation). Recommended Not stated in three studies.
Durda and
Preziosi
Protocol described and followed (standardized protocol/validated
protocol/published peer-reviewed protocol/scientifically accepted




All studies are peer reviewed and non-
standard, but not according to GLP.
Peer-reviewed study Recommended All studies are peer reviewed.
Schneider
et al.
Is the study design chosen appropriate for obtaining the substance-
specific data aimed at?
Mandatory, 0,
or 1
Appropriate study design for dose-response
analyses for all studies.
OECD
guidelines
Clear reporting instructions for each test standard. Mandatory The non-standard studies were not
evaluated according to the OECD reporting
requirements.
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interpreted into Schneider et al. [13] method. The
OECD guidelines do not report of any other factors in
addition to the ones mentioned by the four methods.
Result of the study evaluations
The purity of the test substance was not stated in six of
the nine studies. Neither stability nor by-products of the
test substance was stated in any of the studies. Other fac-
tors such as vapor pressure, water solubility, octanol/
water partitioning coefficient (logKow) and bioconcentra-
tion factor were missing in several or all of the studies.
Test environment
Usefulness of proposed criteria
Oxygen concentration, conductivity, temperature, pH,
water hardness, salinity, light intensity, photoperiod,
physical structure of the test chamber, test media, test
organism density, food composition and food availability
are abiotic and biotic factors that the four methods spe-
cify in their evaluation schemes. Several of the reported
factors could modify the toxicity of chemicals [29].
None of the four evaluation methods include all factors.
The OECD guidelines recommend that light quality,
residual chlorine levels, total organic carbon (TOC), and
chemical oxygen demand (COD) are reported in addi-
tion to the other factors.
Schneider et al. [13] did not specify which factors related
to the test environment that should be evaluated and only
consider it relevant for repeated dose toxicity studies.
Klimisch et al. [10] has gathered the factors in only two
criteria, while Durda and Preziosi [11] and Hobbs et al.
[12] have divided the factors into several criteria/questions.
Having one factor per criteria/question facilitates the eva-
luation since only one thing at a time has to be considered.
Durda and Preziosi [11] has, contrary to Klimisch et al.
[10] and Hobbs et al. [12], considered feeding protocols
for long-term tests a “must” criterion.
Result of the study evaluations
None of the nine studies report all “test environment”
factors. Temperature was reported more often than the
other factors, whereas pH and dissolved oxygen (DO)
were the factors that most of the studies failed to report.
In some studies, information was given on the condi-
tions for the cultivation/breeding stock but not for the
experimental setup.
Dosing system
Usefulness of proposed criteria
Administrated concentrations, concentration control
analysis, administration route, frequency and duration of
exposure, and information of the dosing type are aspects
related to the “dosing system” that the four evaluation
methods all together consider as important. Durda and
Preziosi [11] is the only method that covers all aspects.
Both Durda and Preziosi [11] and Schneider et al. [13]
consider administrated concentrations, administration
route, frequency and duration of exposure as “must”
Table 5 OECDs reporting requirements, modified evaluation criteria/questions concerning test substance, and
summary of the evaluation results
Evaluation
method
Evaluation criteria/question Type of criteria/mark Summary of evaluation results
Klimisch
et al.
Specification of the test substance (purity, by-products). Recommended Purity is not stated in six studies, by-
products are not stated in any of these
studies.
Data on neutralization of samples (for basic or acid substances). Recommended Not stated in any of these studies.
Use of emulgators/solubilizers. Recommended Not stated in any of these studies.
Durda and
Preziosi
Chemical species noted. Recommended Stated in all studies.
Chemical source noted. Recommended Not stated in one study.
Purity/stability noted. Recommended Purity is not stated in six studies, stability
is not stated in any of these studies.
Vehicle described (if used). Recommended Not stated in four studies.
Hobbs et al. Were analytical reagent grade chemicals or the highest possible
purity chemicals used for the experiment?
0 or 3 Not stated in six studies.
Schneider
et al.
Is information on the source/origin of the substance given? Recommended, 0, or 1 Not stated in one study.
Was the test substance identified? Mandatory, 0, or 1 Stated in all studies.
Is the purity of the substance given? Recommended, 0, or 1 Not stated in six studies.
Is all information on the nature and/or physicochemical
properties of the test item given, which you deem indispensable
for judging the data?
Recommended, 0, or 1 Not stated in five studies.
OECD
guidelines
Chemical identification data (e.g., CAS Number); physical nature
and relevant physical-chemical properties; water solubility; purity;
stability; suspended solids.
Mandatory The non-standard studies were not
evaluated according to the OECD
reporting requirements.
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criteria. The OECD guidelines also recommend that
date of start of the test; method of preparation of stock
solutions, the recovery efficiency of the method, and the
limit of quantification in the test matrix should be
reported.
Result of the study evaluations
The tested concentrations were not stated in two studies
and in two other studies only the concentration range
was reported. Concentration control analyses were made
in five of the nine studies. The administration routes
were rarely stated explicitly. A possible reason for this is
that it is considered self-evident when it comes to aqua-
tic toxicity testing.
Test species
Usefulness of proposed criteria
Identification of test species, number of individuals, inves-
tigated period of the lifecycle, reproductive condition, sex,
strain, source, body weight, length or mass are aspects
related to the “test species” that the four evaluation meth-
ods all together as consider important. None of the meth-
ods cover all aspects. Only Schneider et al. [13] has a
“must” criterion: identification of the test species. The
OECD guidelines also recommend that culture conditions
and methods of collecting the test species are described.
Result of the study evaluations
Complete information about the test organism was
missing in all nine studies.
Controls
Usefulness of proposed criteria
The reported aspects connected to “controls” are: use
of control (positive, negative and/or solvent), accept-
ability criteria, control media identical to test media in
all respect except the treatment variable, and origin of
the control and test organisms. Only Durda and
Table 6 OECDs reporting requirements, modified evaluation criteria/questions concerning test environment, and
summary of the evaluation results
Evaluation
method
Evaluation criteria/question Type of
criteria/mark
Summary of evaluation results
Klimisch et
al.
Data on physical and chemical test conditions (pH,
conductivity, light intensity, temperature, hardness of
water).
Recommended Temperature is not stated in two studies, pH is not
stated in seven studies, conductivity is not stated in any
of these studies, hardness of water is not stated in any
of these studies, light intensity is not stated in two
studies.
Data on the feeding of the test animals (chronic studies). Recommended Stated in all studies.
Durda and
Preziosi
Water characteristics recorded (e.g., pH, DO, temperature). Recommended Temperature is not stated in two studies, pH is not
stated in seven studies, DO is not stated in three studies.
Light intensity and/or photoperiod. Recommended Not stated in two studies.
Physical structure of test environment recorded. Recommended Not stated in one study.
Number of animals per test apparatus (e.g., aquaria)
noted.
Recommended Not stated in one study.
Feeding protocols noted (long-term tests). Mandatory Not stated in one study.
Food composition noted/known. Recommended Not stated in one study.
Hobbs et al. Was the temperature measured and stated (3 marks)?
Award 1 mark if only the temperature settings of the
room or chamber are stated?
0, 1, or 3 Not stated in two studies and only specified in two
studies.
For tests not using aquatic macrophytes and alga (i.e.,
non-plant), was the dissolved oxygen content of the test
water measured during the test?
0 or 3 Not stated in three out of five studies.
Was the pH measured and values stated? Award 1 mark
if it is measured but not stated or if the pH of the
dilution water only is measured and stated.
0, 1, or 3 Not stated in seven studies.
For marine and estuarine water, was the salinity/
conductivity measured and stated?
0 or 3 No marine studies were evaluated.
Was the type of test media used stated? 0 or 5 Not stated in three studies.
Schneider
et al.
For repeated dose toxicity studies only: Is information
given on the housing or feeding conditions?
Recommended,
0, or 1
No repeated dose toxicity studies were evaluated.
OECD
guidelines
Photoperiod, light intensity and quality (source,
homogeneity); pH values at the beginning and at the
end of the test at all treatments; hardness; temperature;
dissolved oxygen concentration; test vessel description
including volume; detailed information on feeding (e.g.,
type of food(s), source, amount given and frequency);
residual chlorine levels (if measured); TOC and COD;
Salinity of the test medium.
Mandatory The non-standard studies were not evaluated according
to the OECD reporting requirements.
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Preziosi [11] cover all these aspects. Klimisch et al.
[10] does not mention any of the aspects. Both Durda
and Preziosi [11] and Schneider et al. [13] have “must”
criteria/questions. The four methods all together cov-
ered the same aspects as the OECD guidelines.
When it comes to acceptability criteria for the test,
e.g., control mortality, two different approaches can be
seen. Hobbs et al. [12] only requires that the acceptabil-
ity criteria are stated while Durda and Preziosi [11] and
Schneider et al. [13] ask whether the results connected
to the acceptability criteria are reliable or acceptable.
Durda and Preziosi [11] provides a percent limit for the
control mortality while Schneider et al. [13], in the gui-
dance material, asks whether the variability of the results
and control was acceptable and if control values were
within reasonable range.
Result of the study evaluations
In two of the evaluated studies, the authors did not
report whether controls were used or not. Acceptability
criteria were not stated in any of the studies, but since
Schneider et al. [13] asks whether the variability of the
results and control was acceptable, one of the studies
were considered to fulfill this evaluation question. The
origin of the control and test organisms and whether
the control media is identical to test media in all respect
except the treatment variable was not specifically stated
in any of the studies. A possible reason for this could be
that this is considered to be self-evident.
Statistical design
Usefulness of proposed criteria
The reported aspects connected to “statistical design”
are: statistical method and results including significance
levels and estimates of variability, (sufficient) sample
size and replicates, randomized treatments and indepen-
dent observations. None of the methods cover all
aspects. The four methods all together covered the same
aspects as the OECD guidelines. Schneider et al. [13]
Table 7 OECDs reporting requirements, modified evaluation criteria/questions concerning dosing system, and
summary of the evaluation results
Evaluation
method
Evaluation criteria/question Type of
criteria/mark
Summary of evaluation results
Klimisch
et al.
Data on concentration control analysis. Recommended Concentrations are not measured in four studies.
Data on dosing the test substance (static, semi-static, flow
through system).
Recommended Not clearly stated, but could be understood for all but
one study.
Data on the exposure period. Recommended Stated in all studies.
Durda and
Preziosi
Dose (measured preferred). Mandatory Concentration ranges are presented for two studies,
tested concentrations are lacking for two studies,
concentrations are not measured in four studies.
Administration route (environmentally relevant preferred). Mandatory Not clearly stated, but could be understood for all but
one study.
Exposure schedule (intermittent, continuous or ad libitum). Recommended Not stated in one study.
Exposure duration. Mandatory Stated in all studies.
Hobbs et al. Were the chemical concentrations measured? 0 or 4 Concentrations are not measured in four studies.
Was the type of exposure (e.g., static, flow through)
stated?
0 or 4 Not clearly stated, but could be understood for all but
one study.
Was the duration of the exposure stated (e.g., 48 or 96 h)? 0 or 10 Stated in all studies.
Schneider
et al.




Concentration ranges are presented for two studies,
tested concentrations are lacking for two studies.
Concentrations are not measured in four studies.
For inhalation studies and repeated dose toxicity studies
only (give point for other study types): Were achieved
concentrations analytically verified or was stability of the
test substance otherwise ensured or made plausible?
Recommended,
0, or 1
No inhalation and/or repeated dose toxicity study was
evaluated.
Is the administration route given? Mandatory, 0, or
1
Not clearly stated, but could be understood for all but
one study.
Are sufficient details of the administration scheme given
to judge the study?
Recommended,
0, or 1
Not stated in three studies.
Are frequency and duration of exposure as well as time-
points of observations explained?
Mandatory, 0, or
1
Stated in all studies.
OECD
guidelines
Date of start of the test; test duration; test procedure used
(e.g., semi-static or flow through); method of preparation
of stock solutions; test concentrations, nominal and
measured; the recovery efficiency of the method; the limit
of quantification in the test matrix.
Mandatory The non-standard studies were not evaluated according
to the OECD reporting requirements.
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Table 8 OECDs reporting requirements, modified evaluation criteria/questions concerning test species, and summary
of the evaluation results
Evaluation
method
Evaluation criteria/question Type of
criteria/mark
Summary of evaluation resultsa
Klimisch et
al.
Data on the test species and the number of individuals tested. Recommended Not stated in one study.
Information about the investigated period of the life cycle of the
test animals (chronic studies).
Recommended Not stated in three studies.
Durda and
Preziosi
Body weight or length. Recommended Not stated in two studies.
Age/life stage. Recommended Not stated in three studies.
Reproductive condition. Recommended Not stated in four studies.
Gender. Recommended Not stated in one study.
Strain. Recommended Not stated in four studies.
Source. Recommended Not stated in one study.
No previous exposure (e.g., for field-collected specimens). Recommended No field-collected test species.
No concomitant exposure (e.g., during field studies). Recommended No field studies.
Hobbs et al. Were the characteristics of the test organism (e.g., length, mass, age)
stated?
0 or 5 Not stated in two studies.
Schneider
et al.
Is the species given? Mandatory, 0, or
1
Stated in all of the studies.




Body weight is not stated in two studies, age
is not stated in three studies.
Is the sex of the test organism given? Recommended,
0, or 1
Not stated in one study.
Is information given on the strain of test animals plus, if considered




Not stated in four studies.
OECD
guidelines
Scientific name; strain/clone; source; culture conditions including
medium and volume; methods of collection.
Mandatory The non-standard studies were not evaluated
according to the OECD reporting
requirements.
aSome aspects are not relevant for all studies, depending on choice of test species. This has been considered in the evaluation.




Evaluation criteria/question Type of
criteria/mark
Summary of evaluation results
Durda and
Preziosi
Control media identical to test media in all respect except the
treatment variable.
Mandatory Not stated in any of these studies, controls not
stated at all in two studies.
Control and test organism drawn from same population. Mandatory Not stated in any of these studies, controls not
stated at all in two studies.
Acceptable control mortality/morbidity (approx. 10%). Mandatory Not stated in any of these studies.
Vehicle control (as appropriate). Recommended Not stated in six studies.
Positive and/or negative control (optional). Recommended Controls not stated in two studies.
Hobbs et al. Were test acceptability criteria stated (e.g., mortality in controls
must not exceed a certain percentage) OR
0 or 5 Not stated in any of these studies.
Were the acceptability criteria inferred (e.g., test method used
[USEPA, OECD, ASTM etc.] uses validation criteria) (award 2 marks).
0, 2, or 5 No standard tests were evaluated.
Were appropriate controls (e.g., no-toxicant control and/or solvent
control) used?
0 or 5 Not stated in two studies.
Were parallel reference toxicant toxicity test conducted? 0 or 4 Not stated in any of these studies.
Schneider
et al.
Were negative (where required) and positive controls (where




Not stated in two studies.




Not stated in eight studies.
OECD
guidelines
Evidence that controls met the overall survival acceptability
standard of the test species.
Mandatory The non-standard studies were not evaluated
according to the OECD reporting requirements.
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has a “must” criterion: the number of animals has to be
stated. Hobbs et al. [12] and Durda and Preziosi [11]
instead ask for at least two replicates or sufficient sam-
ple size/replicates.
Result of the study evaluations
The statistical model used was not stated by two studies,
results from the statistical calculations were missing for
another one. The significance level or the estimation of
Table 10 OECDs reporting requirements, modified evaluation criteria/questions concerning statistical design, and
summary of the evaluation results
Evaluation
method
Evaluation criteria/question Type of
criteria/mark
Summary of evaluation results




Sufficient sample size/replicates. Recommended Not stated in one study, sufficient in all
other studies.
Randomized treatments. Recommended Not stated in any of these studies.
Independence of observations. Recommended Not stated in any of these studies.
Appropriate statistical model. Recommended Not stated in two studies.
Statistically significant responses noted. Recommended Not stated in three studies.
Hobbs et al. Was each control and chemical concentration at least duplicated? 0 or 5 Not stated in one study, controls not
stated in two studies.
Was an appropriate statistical method or model used to
determine the toxicity?
0 or 4 Not stated in two studies.
For NOEC and LOEC data was the significance level 0.05 or less?
or FOR LC and EC data was an estimate of variability provided?
0 or 4 Not stated in five studies.
Schneider et al. Is the number of animals per group given? Mandatory, 0, or
1
Not stated in one study.
Are the statistical methods applied for data analysis given and
applied in a transparent manner?
Recommended,
0, or 1
Not stated in three studies.
OECD guidelines Statistical analysis and treatment of data; number of test
chambers and replicates; number of embryos per replicate; if
ANOVA has been used, the size of the effect which can be
detected (e.g., the least significant difference).
Mandatory The non-standard studies were not
evaluated according to the OECD
reporting requirements.
Table 11 OECDs reporting requirements, modified evaluation criteria/questions concerning biological effect, and
summary of the evaluation results
Evaluation
method
Evaluation criteria/question Type of
criteria/mark
Summary of evaluation results




Quantitative measurement of response. Recommended Stated in all studies.
Results reproduced by others. Recommended Not considered.
Consistent with other findings. Recommended Not considered.
Dose-response observed. Recommended Not stated in three studies, no
relationship in one study.
Hobbs et al. Was the biological effect stated (e.g., LC or NOEC)? 0 or 5 Not stated in one study but could be
understood.
Was the biological effect quantified (e.g., 50% effect, 25% effect)?
The effect for NOEC and LOEC data must be quantified.
0 or 5 Info about tested concentrations is
missing for one LOEC/NOEC value.
Was there a concentration-response relationship either observable
or stated?
0 or 4 Not stated in three studies, no
relationship for one study.
Schneider et al. Is the description of the study results for all endpoints
investigated transparent and complete?
Recommended,
0, or 1
Not stated in four studies.
OECD guidelines Concentration-response data, the slope of the dose-response
curve and its standard error; EC50 or EC10 and associated
confidence intervals; LOEC and NOEC and the statistical methods
used for their determination; calculated response variables for
each treatment replicate, with mean values and coefficient of
variation for replicates.
Mandatory The non-standard studies were not
evaluated according to the OECD
reporting requirements.
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variability was missing for five studies. Eight of the nine
studies used a sufficient sample size but none stated
whether treatments were randomized or how observa-
tions were made. A possible reason for not reporting
this could be that it is considered being self-evident, or
that the researchers use traditional and widely accepted
statistical methods.
Biological effect
Usefulness of proposed criteria
The reported aspects connected to “biological effect”
are: stated and quantified effects for all endpoints, con-
centration-response relationship, and whether the results
have been reproduced by others or are consistent with
other findings. Durda and Preziosi [11] have covered all
aspects. The OECD guidelines also recommend that cal-
culated response variables for each treatment replicate,
with mean values and coefficient of variation for repli-
cates is reported.
Result of the study evaluations
All but one study had a determined EC50, LOEC, NOEC
or NOEL value (no observed effect level). There was no
concentration-response relationship reported in one
study and unclear in three other studies.
Summary of the evaluation of existing reliability evaluation
methods
The four reliability evaluation methods are described and
compared in Table 12. The results from the evaluation are
discussed in three parts: Scope; How evaluation criteria
are weighted and summarized; User friendliness. Conclu-
sions from this evaluation are presented in the last section.
Scope
The four methods differ in their scope. Durda and Preziosi
[11] have twice as many criteria as the other methods.
Still, the four methods all include criteria from the same
categories with the exception of Klimisch et al. [10] and
Hobbs et al. [12] that lack criteria concerning controls and
protocol, respectively. The Schneider et al. [13] method
also includes aspects that are related to relevance.
The criteria vary in extent and specification, e.g.,
Hobbs et al. [12] have one criterion in the test species
category while Durda and Preziosi [11] use eight differ-
ent criteria for the same issue (see Table 8). A disadvan-
tage of using wide or unspecified criteria is that aspects
could be forgotten about. A disadvantage of using too
precise criteria is decreased flexibility.
Another example deals with criteria concerning dose/
concentration. Hobbs et al. [12] and Klimisch et al. [10]
Table 12 Description and comparison of the four reliability evaluation methods
Klimisch et al. Durda and Preziosi Hobbs et al. Schneider et al.
Data types Toxicity (in vivo and in vitro) and
ecotoxicity (acute and chronic)
data.
Ecotoxicity data. Ecotoxicity (both acute and
chronic) data.
Toxicity data (both in vivo and in
vitro).





reliable with restrictions, not
reliable and not assignable.
High, moderate and low





reliable with restrictions, not
reliable and not assignable.
No. of evaluation
criteria/questions
12 (acute ecotoxicity), 14 (chronic
ecotoxicity).
40 20 21
No. of aspects per
criteria/questions






between 0 and 10.
Recommended and mandatory,












Recommended in the REACH
guidance document for industrial
chemicals [39].
Based on standards from
US EPA, OECD and ASTM.










14/37 22/37 15/37 14/37
US EPA United States Environmental Protection Agency, OECD Organisation for Economic Co-operation and Development, ASTM American Society for Testing and
Materials.
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do not explicitly state that the doses should be reported.
The Schneider et al. [13] criteria could be interpreted in
different ways; it is not clear whether nominal or mea-
sured concentrations are required.
There are also some examples of criteria where a
minimum level is presented, e.g., Hobbs et al. [12] cri-
teria ask whether each control and chemical concentra-
tion is at least duplicated. Others leave more to the
evaluator by asking if the sample size and replicates is
sufficient (see [11]).
When it comes to acceptability criteria, e.g., 10% mor-
tality in the control, two different approaches can be
seen. Either that the acceptability criteria are stated [12]
or the requirement that the results connect to the
acceptability criteria are reliable or acceptable [11,13].
The different approaches put different demands on the
evaluator.
Durda and Preziosi [11], Hobbs et al. [12] and Schnei-
der et al. [13] all have unique evaluation criteria that
the other methods are missing.
The method described by Durda and Preziosi [11] has
been developed from guidelines and it is therefore not
surprising that this method has the highest resemblance
with the OECD reporting requirements, 22 out of 37
criteria. The other three methods have each included
less than half of the OECD reporting requirements in
their list of criteria.
Some of the reporting requirements in the OECD
guidelines were not reported by any of the four evalua-
tion methods: date of start of the test; method of pre-
paration of stock solutions; the recovery efficiency of the
method; the limit of quantification in the test matrix;
culture conditions; methods of collection; light quality;
residual chlorine levels; TOC and COD; and the coeffi-
cient of variation. Several of these reporting require-
ments could be important for a general reliability
evaluation.
How evaluation criteria are weighted and summarized
The four methods differ in how criteria are weighted
and summarized.
Klimisch et al. [10] have not weighted their criteria
and have not stated how to summarize the evaluation;
this could result in a wide range of reliability evaluation
results for the same test data. Klimisch et al. [10] has
reserved the highest reliability category for studies car-
ried out according to accepted guidelines and preferably
performed according to good laboratory practice (GLP),
or for methods that are very similar to a guideline
method. This means that a study that has a design that
is significantly different from standard test methods can
never be put in the highest reliability category.
Durda and Preziosi [11] distinguish between manda-
tory and optional criteria. All mandatory criteria have to
be fulfilled to receive the lowest acceptable reliability
criteria and the highest reliability category is reserved
for studies that fulfill all 40 evaluation criteria. GLP is
preferred and the highest reliability category applies to
standard tests or test closely related to standard tests.
However, in practice, it is possible that non-standard
tests fulfill all criteria, except the one regarding GLP,
regardless of whether the test is closely related to a
standard test or not.
Hobbs et al. [12] has weighted the criteria by assign-
ing scores between 0 and 10. The total score for each
study is then divided with the total possible score,
which varies depending on what type of chemical, test
organism and test media, and this results in a quality
score and a quality class.
Schneider et al. [13] have divided their evaluation
questions into mandatory and optional. All mandatory
criteria have to be fulfilled to receive the lowest accepta-
ble reliability category. The highest reliability category is
reserved for studies which fulfill all mandatory evalua-
tion questions and at least 18 of the 21 evaluation ques-
tions in total. This method differed from the other
methods by, in our evaluation, assigning studies the
highest reliability category (see the Summary of the
reliability evaluation of the non-standard test data
section).
User friendliness
User friendliness is defined in this study as a method
that has clear instructions and an uncomplicated
procedure.
All four methods include evaluation criteria that are
wide and imprecise which opens up for a variety of dif-
ferent interpretations. Klimisch et al. [10] and Schneider
et al. [13] compound criteria, i.e., criteria that include
several aspects. Having more delimited criteria/questions
facilitates the evaluation since only one aspect at a time
has to be considered.
Additional information that complements the evalua-
tion criteria/questions makes an evaluation method easy
to use. Both Durda and Preziosi [11] and Schneider et
al. [13] have useful additional guidance.
The Klimisch method [10] lacks information how to
summarize the evaluation. This complicates the work of
the evaluator. Schneider [13] summarizes the results
automatically in a pre-formatted excel-sheet. Both
Durda and Preziosi [9] and Hobbs et al. [12] apply man-
ual summarization of the evaluations.
Conclusions from the evaluation of existing reliability
evaluation methods
The evaluation methods differ in their scope, user
friendliness, and how criteria are weighted and summar-
ized. Depending on the evaluators’ previous experience
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and knowledge, the outcome of the different methods
can therefore differ. For the evaluators, it is important
to be aware of the different methods strengths and
limitations.
Durda and Preziosi [11] provide the method with the
broadest scope and it also had the highest resemblance
with the OECD guidelines. Durda and Preziosi [9],
Hobbs et al. [12] and Schneider et al. [13] differ in how
evaluation criteria are weighted and summarized but all
three methods are functional and understandable. Durda
and Preziosi [9] and Schneider et al. [13] both provide
useful guidance information to the risk assessors which
enhance the user friendliness.
Summary of the reliability evaluation of the non-standard
test data
All four methods require some degree of expert judg-
ment. They are developed to help risk assessors evaluate
data, not to replace the risk assessor. Therefore it is
likely that two experts evaluating the same study end up
with slightly different results depending on their exper-
tise and previous experiences. We have in our evalua-
tion strived to make a uniform treatment of the
evaluation methods and the selected studies. The eva-
luation method described by Klimisch et al. [10]
requires more expert judgment when the evaluation is
merged since instructions for this is lacking.
A striking result of this exercise is that many of the
aspects considered important in the different evaluation
methods are not reported by the authors of the selected
studies. Examples of aspects often omitted are informa-
tion about the controls, results from statistical evalua-
tions, whether there is a dose-response relationship or
not, tested concentrations, and clear description of the
test environment. To safeguard against under-reporting,
we recommend that a checklist containing all applicable
reliability criteria should be used.
Overall the evaluation of the nine selected non-stan-
dard tests resulted in a low number of studies with
acceptable reliability. The nine selected studies were
evaluated by four different methods which resulted in
36 evaluations. Only 14 (39%) of these resulted in accep-
table quality, reliable with restrictions, or reliable with-
out restrictions (Table 13).
Also, the result from the four evaluation methods dif-
fered at a surprisingly high rate. Using the four methods
lead to the same evaluation result for two studies only
[14,15], both were summarized as studies with unaccep-
table quality/not reliable. The evaluation result differed
by one quality data level, from unacceptable quality/not
reliable to acceptable quality/reliable with restrictions, for
five studies [16-20] and by two quality data levels, from
unacceptable quality/not reliable to high quality/reliable
without restrictions, for two studies [21,22] (Table 13).
Durda and Preziosi [11] did not accept any of the stu-
dies since the mandatory criteria acceptable control
mortality/morbidity was not reported. Hobbs et al. [12]
has a similar criterion but since it is not mandatory it
does not have the same effect on the summarized
evaluations.
Other reasons why the reliability was considered unsa-
tisfactory according to one or more evaluation method
were lack of information about: chemical concentration
control analysis, physical and chemical test conditions,
specification of the test substance, a clear description of
the test procedure, and the investigated period of the
life cycle of the test organisms.
Discussion and conclusions
Standard test data are still preferred for regulatory
environmental risk assessments of pharmaceutical sub-
stances. Accepting non-standard test data is likely to
increase the regulatory agencies’ work load since it is
more complicated to evaluate these data compared to
relying on standards only. More structured evaluation
methods can help risk assessors and evaluators to use
non-standard test data. But, as we have shown in this
study, the design of the evaluation method is crucial
since it can affect the outcome of the evaluation
significantly.
The evaluation methods scrutinized in this study all
require expert judgement. In our view, it is neither pos-
sible nor desirable to develop a method that completely
leaves out expert judgement, but we can strive towards
a method that reduces vagueness and elements of case-
by-case interpretations. Both Hobbs et al. [12] and
Schneider et al. [13] have tested and modified their
respective method during the development process in
order to increase the likelihood that evaluators arrive at
similar conclusions.
The actual use of the four evaluation methods is
unclear but Klimisch et al. [10] has been cited 62 times,
Table 13 Summary of the reliability evaluation of non-
standard test data
Reference Evaluation method
Klimisch Durda Hobbs Schneider
Andreozzi et al. [14] - - - -
Ferrari et al. [15] - - - -
Huggett et al. [16] - - + -
Robinson et al. [17] + - + -
Schmitt-Jansen et al. [18] + - + -
Quinn et al. [19] - - + -
Metcalfe et al. [20] - - + +
Nentwig [21] + - + ++
Halm et al. [22] + - + ++
- Unacceptable quality/not reliable, + acceptable quality/reliable with
restrictions, ++ high quality/reliable without restrictions.
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Schneider et al. [13] seven times, Durda and Preziosi
[11] twice, and Hobbs et al. [12] once (ISI Web of
Knowledge, 2010-11-02). The method described by
Hobbs et al. [12] has, according to the authors them-
selves, been used by several Australian and New Zealand
authorities.
The problem with non-standard data found to have
low reliability could be either that the studies are poorly
performed or that they are under-reported. Under-
reporting could be a consequence from journals’ desire
to publish concise papers. However, an increasing num-
ber of journals provide possibilities to include additional
data as supplementary electronic information which
means that this should not be a major obstacle for mak-
ing such information publicly available. It is also well
known that environmental factors, such as oxygen
saturation, salinity, pH, hardness, and temperature, can
have drastic impact on uptake and effects of chemical
substances [e.g., [30-32]] and therefore, as proposed by
most standard protocols, these aspects need to be moni-
tored and reported in order to ensure the reproducibility
of the test data, i.e., a key issue in the scientific process.
For the nine studies investigated in the present paper,
under-reporting could very well be a significant reason
for the evaluation outcome. Aspects like use of controls,
results from statistical evaluations, whether there are a
concentration-response relationships or not, tested con-
centrations and clear description of the test subject and
test environment are important and should be included
in all publications presenting ecotoxicity data. Reliability
evaluation methods can be used as checklists for authors
and reviewers to ensure that all important aspects of the
test method are included in their reports. A more struc-
tured reporting format could ensure the reliability of the
test data without limiting the researcher’s creativity in
the design of a non-standard study.
As it is today, data with low reliability will not be
included in regulatory environmental risk assessment.
We believe that none of the nine selected non-standard
studies could have been used in an environmental risk
assessment of pharmaceuticals according to the EMA
guideline. However, we still see that the studies could
contribute to the risk assessment by acting as support-
ing information. We are currently developing a new sug-
gestion on how to report and evaluate ecotoxicity data
from the open scientific literature in regulatory risk
assessment of pharmaceuticals. The new set of criteria is
developed in collaboration between regulators at the
German Federal Environment Agency (UBA) and
researchers within the Swedish research program Mis-
traPharma http://www.mistrapharma.se[33]. The criteria
are based on the four methods evaluated in this study
and the OECD reporting requirements, and have been
further developed to include both reliability and
relevance of test data. Intended users are risk assessors
and researchers performing ecotoxicological experi-
ments, but the criteria can also be used for education
purposes and in the peer-review process for scientific
papers. This approach intends to bridge the gap between
the regulator and the scientist’s needs and way of work.
It is important to remember that much of the research
done within the field of ecotoxicology and risk assess-
ment is financed through tax payer’s money and to not
find a way for use of this data in risk assessments would
be an inefficient and irresponsible handling of resources.
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